Characteristics and predictors of drug-eluting stent thrombosis: results from the multicenter 'Korea Stent Thrombosis (KoST)' registry.
暂无分享,去创建一个
M. Jeong | K. Seung | Seung‐Jung Park | Y. Jang | Young‐Bae Park | B. Oh | Hyo‐Soo Kim | H. Gwon | Kyung-Woo Park | T. Ahn | I. Chae | J. Yoon | S. Tahk | Dong-A Kwon | Seok-Jae Hwang | S. Hwang
[1] D. Kereiakes. Safety of drug-eluting stents. , 2010, Reviews in cardiovascular medicine.
[2] T. Kume,et al. Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents: Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) , 2010, Circulation.
[3] L. Thuesen,et al. Late coronary stent thrombosis. , 2010, Minerva medica.
[4] B. Yoo,et al. The Significance of Clopidogrel Low-Responsiveness on Stent Thrombosis and Cardiac Death Assessed by the Verifynow P2Y12 Assay in Patients With Acute Coronary Syndrome Within 6 Months After Drug-Eluting Stent Implantation , 2009, Korean circulation journal.
[5] Yoshinobu Morikawa,et al. Long-term follow-up of neointimal coverage of sirolimus-eluting stents--evaluation with optical coherence tomography. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[6] R. Starzyk,et al. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. , 2009, Circulation. Cardiovascular interventions.
[7] K. Hirata,et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[8] K. Filion,et al. Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents , 2009, Circulation.
[9] Y. Hayashi,et al. Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation , 2009, Circulation.
[10] M. Jeong,et al. A Fatal Case of Simultaneous, Very Late Thrombosis Involving Three Drug-Eluting Stents in Three Coronary Arteries , 2008 .
[11] A. Gori,et al. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. , 2008, Journal of the American College of Cardiology.
[12] Josepa Mauri,et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). , 2008, Journal of the American College of Cardiology.
[13] R. Waksman,et al. Drug-eluting stent safety. , 2007, The American journal of cardiology.
[14] E. Camenzind,et al. Response to Letter Regarding Article, “Stent Thrombosis Late After Implantation of First-Generation Drug-Eluting Stents: A Cause for Concern” , 2007 .
[15] A. Colombo,et al. Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment , 2007, Circulation.
[16] A. Gori,et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. , 2007, Journal of the American College of Cardiology.
[17] Rolf Vogel,et al. Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation , 2007, Circulation.
[18] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[19] G. Stone,et al. Clinical ResearchInterventional CardiologyIncidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent: A TAXUS II, IV, V, and VI Meta-Analysis of 3,445 Patients Followed for Up to 3 Years , 2007 .
[20] Marco Valgimigli,et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.
[21] Ralph D'Agostino,et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. , 2007, The New England journal of medicine.
[22] S. Pocock,et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.
[23] Neville Kukreja,et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.
[24] Seung‐Jung Park,et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. , 2006, The American journal of cardiology.
[25] K. Kent,et al. Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents , 2006, Circulation.
[26] A. Hedger,et al. Cause for concern , 2005, British Dental Journal.
[27] Deepak L. Bhatt,et al. Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). , 2005, The American journal of cardiology.
[28] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.
[29] P. Serruys,et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. , 2005, Journal of the American College of Cardiology.
[30] Deepak L. Bhatt,et al. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. , 2005, Journal of the American College of Cardiology.
[31] Fernando Alfonso,et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. , 2005, Journal of the American College of Cardiology.
[32] David J Cohen,et al. Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation , 2004, Circulation.
[33] D. Baim,et al. Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.
[34] M. Gawaz,et al. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions. , 2010, European heart journal.